UA98506C2 - Attenuated mycoplasma gallisepticum strains - Google Patents
Attenuated mycoplasma gallisepticum strainsInfo
- Publication number
- UA98506C2 UA98506C2 UAA201002676A UAA201002676A UA98506C2 UA 98506 C2 UA98506 C2 UA 98506C2 UA A201002676 A UAA201002676 A UA A201002676A UA A201002676 A UAA201002676 A UA A201002676A UA 98506 C2 UA98506 C2 UA 98506C2
- Authority
- UA
- Ukraine
- Prior art keywords
- mycoplasma gallisepticum
- attenuated mycoplasma
- gallisepticum strains
- strains
- attenuatedbacteria
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/35—Mycoplasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Изобретение относится к ослабленному штамму бактерий, проявляющему сниженную экспрессию белка MGA_0621 и имеющему депозитарный номер АТСС РТА-8485. Также изобретение относится к вакцине и способу вакцинации, которые основываются на применении ослабленного штамма бактерий.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99344707P | 2007-09-11 | 2007-09-11 | |
PCT/US2008/010630 WO2009035644A1 (en) | 2007-09-11 | 2008-09-10 | Attenuated mycoplasma gallisepticum strains |
Publications (1)
Publication Number | Publication Date |
---|---|
UA98506C2 true UA98506C2 (en) | 2012-05-25 |
Family
ID=40024216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201002676A UA98506C2 (en) | 2007-09-11 | 2008-09-10 | Attenuated mycoplasma gallisepticum strains |
Country Status (22)
Country | Link |
---|---|
US (4) | US7935356B2 (ru) |
EP (2) | EP2564868A1 (ru) |
JP (2) | JP5451619B2 (ru) |
KR (2) | KR101176717B1 (ru) |
CN (1) | CN101896195B (ru) |
AR (1) | AR068418A1 (ru) |
AU (1) | AU2008299913B2 (ru) |
BR (1) | BRPI0817334A8 (ru) |
CA (1) | CA2699410C (ru) |
CL (1) | CL2008002675A1 (ru) |
CO (1) | CO6260102A2 (ru) |
ES (1) | ES2437593T3 (ru) |
HK (1) | HK1145627A1 (ru) |
ME (1) | ME00982B (ru) |
MX (1) | MX2010002866A (ru) |
NZ (1) | NZ583829A (ru) |
PL (1) | PL2200640T3 (ru) |
RU (1) | RU2441909C2 (ru) |
TW (1) | TW200918666A (ru) |
UA (1) | UA98506C2 (ru) |
WO (1) | WO2009035644A1 (ru) |
ZA (1) | ZA201001740B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090068231A1 (en) * | 2007-09-11 | 2009-03-12 | Wyeth | Live attenuated mycoplasma strains |
TW200918666A (en) * | 2007-09-11 | 2009-05-01 | Wyeth Corp | Attenuated mycoplasma gallisepticum strains |
UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
MX2012013409A (es) | 2010-05-19 | 2013-03-07 | Bioproperties Pty Ltd | Metodos relacionados a un micoplasma atenuado. |
CN102168073B (zh) * | 2010-11-30 | 2013-03-20 | 瑞普(保定)生物药业有限公司 | 一种提高疫苗生产中鸡毒支原体增殖能力的方法 |
CN103074246B (zh) * | 2012-08-31 | 2015-09-02 | 南京天邦生物科技有限公司 | 一种低血清高效培养鸡毒支原体弱毒株培养基及其制备方法 |
CN107446859B (zh) * | 2017-09-02 | 2020-12-18 | 河南省农业科学院畜牧兽医研究所 | 一株鸡毒支原体及其应用 |
CN112159479B (zh) * | 2020-10-15 | 2022-03-22 | 福建农林大学 | 一种鸡毒支原体多抗原表位融合蛋白pMG-mEA及其应用 |
CN114045298B (zh) * | 2021-09-09 | 2023-10-20 | 武汉科前生物股份有限公司 | 一种鸡滑液囊支原体亚单位疫苗及制备方法及应用 |
CN114940955B (zh) * | 2022-05-10 | 2023-08-11 | 兆丰华生物科技(南京)有限公司 | 一种鸡毒支原体弱毒疫苗株及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2566833B1 (fr) * | 1984-06-27 | 1986-11-14 | Inst Francais Du Petrole | Methode et perfectionnement aux outils de forage comportant des passages d'eau permettant une grande efficacite du nettoyage du front de taille |
DE3881993T2 (de) * | 1987-09-18 | 1993-09-30 | Akzo Nv | Mycoplasma-Impfstoff. |
US6006134A (en) * | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US7599736B2 (en) * | 2001-07-23 | 2009-10-06 | Dilorenzo Biomedical, Llc | Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease |
EP1063297B1 (en) * | 1999-06-22 | 2008-12-17 | Korea Kumho Petrochemical Co. Ltd. | Farnesyl pyrophosphate synthase (FPS) derived from seedlings of sunflower (Helianthus annus) |
JP4723707B2 (ja) * | 1999-12-22 | 2011-07-13 | パナソニック電工株式会社 | 痩身器具 |
US6885888B2 (en) * | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
US6922590B1 (en) * | 2000-11-21 | 2005-07-26 | Advanced Bionics Corporation | Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion |
US20020187162A1 (en) * | 2001-04-21 | 2002-12-12 | Geary Steven J. | Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease |
US6721603B2 (en) * | 2002-01-25 | 2004-04-13 | Cyberonics, Inc. | Nerve stimulation as a treatment for pain |
US7551964B2 (en) * | 2002-03-22 | 2009-06-23 | Leptos Biomedical, Inc. | Splanchnic nerve stimulation for treatment of obesity |
US7239912B2 (en) * | 2002-03-22 | 2007-07-03 | Leptos Biomedical, Inc. | Electric modulation of sympathetic nervous system |
US7076292B2 (en) * | 2002-04-25 | 2006-07-11 | Medtronic, Inc. | Optical communication of neurostimulation-system information |
US7217420B2 (en) * | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
US7155278B2 (en) * | 2003-04-21 | 2006-12-26 | Medtronic, Inc. | Neurostimulation to treat effects of sleep apnea |
PT1651260E (pt) * | 2003-07-25 | 2009-09-24 | Boehringer Ingelheim Vetmed | Lawsonia intracellularis de origem europeia e vacinas, agentes de diagnóstico e métodos para sua utilização |
TW200918666A (en) * | 2007-09-11 | 2009-05-01 | Wyeth Corp | Attenuated mycoplasma gallisepticum strains |
-
2008
- 2008-09-09 TW TW097134587A patent/TW200918666A/zh unknown
- 2008-09-09 CL CL2008002675A patent/CL2008002675A1/es unknown
- 2008-09-10 EP EP12192086A patent/EP2564868A1/en not_active Withdrawn
- 2008-09-10 WO PCT/US2008/010630 patent/WO2009035644A1/en active Application Filing
- 2008-09-10 ES ES08830621.2T patent/ES2437593T3/es active Active
- 2008-09-10 MX MX2010002866A patent/MX2010002866A/es active IP Right Grant
- 2008-09-10 KR KR1020107007701A patent/KR101176717B1/ko not_active IP Right Cessation
- 2008-09-10 EP EP08830621.2A patent/EP2200640B1/en not_active Not-in-force
- 2008-09-10 CA CA2699410A patent/CA2699410C/en not_active Expired - Fee Related
- 2008-09-10 AU AU2008299913A patent/AU2008299913B2/en not_active Ceased
- 2008-09-10 CN CN200880115552XA patent/CN101896195B/zh not_active Expired - Fee Related
- 2008-09-10 UA UAA201002676A patent/UA98506C2/ru unknown
- 2008-09-10 RU RU2010108641/10A patent/RU2441909C2/ru not_active IP Right Cessation
- 2008-09-10 PL PL08830621T patent/PL2200640T3/pl unknown
- 2008-09-10 US US12/207,750 patent/US7935356B2/en active Active
- 2008-09-10 ME MEP-2010-48A patent/ME00982B/me unknown
- 2008-09-10 KR KR1020117030531A patent/KR20120014041A/ko not_active Application Discontinuation
- 2008-09-10 NZ NZ583829A patent/NZ583829A/en not_active IP Right Cessation
- 2008-09-10 JP JP2010524865A patent/JP5451619B2/ja not_active Expired - Fee Related
- 2008-09-10 BR BRPI0817334A patent/BRPI0817334A8/pt not_active Application Discontinuation
- 2008-09-11 AR ARP080103956A patent/AR068418A1/es unknown
-
2010
- 2010-03-11 ZA ZA2010/01740A patent/ZA201001740B/en unknown
- 2010-03-15 CO CO10030400A patent/CO6260102A2/es active IP Right Grant
- 2010-12-22 HK HK10111979.0A patent/HK1145627A1/xx not_active IP Right Cessation
-
2011
- 2011-03-25 US US13/071,601 patent/US8298552B2/en not_active Expired - Fee Related
-
2012
- 2012-09-26 US US13/626,944 patent/US20130022547A1/en not_active Abandoned
-
2013
- 2013-07-25 US US13/950,910 patent/US20130302373A1/en not_active Abandoned
- 2013-10-31 JP JP2013226338A patent/JP2014027950A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA98506C2 (en) | Attenuated mycoplasma gallisepticum strains | |
MX2021000285A (es) | Composiciones que comprenden cepas bacterianas. | |
WO2016019134A8 (en) | Flagellin-based agents and uses including effective vaccination | |
MX2010003719A (es) | Vacuna de mycoplasma bovis y metodos de uso de la misma. | |
MX2011010976A (es) | Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion. | |
IN2014DN08830A (ru) | ||
MX2010012999A (es) | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. | |
MX2015000287A (es) | Vectores para la transformacion de mycoplasma hyopneumoniae, cepas transformadas de m. hyopneumoniae, y uso correspondiente. | |
MX2010002867A (es) | Cepas de micoplasma atenuadas vivas. | |
PH12014502855A1 (en) | Attenuated streptococcus suis vaccines and methods of making and use thereof | |
MX2010000864A (es) | Vacuna de celulas enteras estafilococcicas inactivadas. | |
MY184865A (en) | Novel bacillus subtilis | |
MX2017016401A (es) | Composiciones inmunogenas. | |
WO2007053489A3 (en) | Attenuated salmonella enterica serovar paratyphi a and uses thereof | |
NZ589981A (en) | Cattle vaccines comprising a disrupted M. bovis bacterium | |
GB2515222A (en) | Use of flagellin as a vaccine | |
MX2011005281A (es) | Vacuna marcadora de salmonella. | |
MX2020007246A (es) | Diseño de vacuna integral para el avance de enfermedad comensal. | |
EA201291175A1 (ru) | Способы, относящиеся к аттенуированной микоплазме | |
MY158116A (en) | Combination vaccine against streptococcus | |
MX2018012312A (es) | Lactobacillus rhamnosus para su uso en la preparacion de productos fermentados. | |
TH103204B (th) | สายพันธุ์ไมโคพลาสมาแกลลิเซพทิคัมที่ถูกทำให้อ่อนกำลังลง | |
GB2515669A (en) | Bacterial vaccine | |
TH135890A (th) | วัคซีนเชื้อเป็นที่ได้รับการดัดแปรปรับปรุงของ Mycoplasma bovis, วิธีการผลิตวัคซีน เชื้อเป็นที่ได้รับการดัดแปรของ Mycoplasma bovis, วัคซีนรวม และวิธีการรักษา |